Active clinical pulmonary sarcoidosis is characterized by significantly reduced apoptosis rate of alveolar lymphocytes (AL)

T. Wandtke (Bydgoszcz, Poland), P. Kopinski (Krakow, Poland), G. Przybylski (Bydgoszcz, Poland), E. Wedrowska (Bydgoszcz, Poland), M. Gnass (Krakow, Poland), J. Golinska (Bydgoszcz, Poland), K. Szablowska (Bydgoszcz, Poland), J. Chorostowska-Wynimko (Warsaw, Poland)

Source: Virtual Congress 2020 – Sarcoidosis: from genetics to epidemiology
Session: Sarcoidosis: from genetics to epidemiology
Session type: Oral Presentation
Number: 4393

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Wandtke (Bydgoszcz, Poland), P. Kopinski (Krakow, Poland), G. Przybylski (Bydgoszcz, Poland), E. Wedrowska (Bydgoszcz, Poland), M. Gnass (Krakow, Poland), J. Golinska (Bydgoszcz, Poland), K. Szablowska (Bydgoszcz, Poland), J. Chorostowska-Wynimko (Warsaw, Poland). Active clinical pulmonary sarcoidosis is characterized by significantly reduced apoptosis rate of alveolar lymphocytes (AL). 4393

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: